Thu, February 23, 2023
Wed, February 22, 2023
Tue, February 21, 2023
Mon, February 20, 2023
Fri, February 17, 2023

Yigal Nochomovitz Maintained (APLS) at Strong Buy with Increased Target to $91 on, Feb 21st, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-91-on-feb-21st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Yigal Nochomovitz of Citigroup, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $86 to $91 on, Feb 21st, 2023.

Yigal has made no other calls on APLS in the last 4 months.



There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 3 agree with Yigal's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Held Target at $58 on, Tuesday, January 3rd, 2023
  • Chris Howerton of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Thursday, November 10th, 2022
  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $43 on, Tuesday, November 8th, 2022


This is the rating of the analyst that currently disagrees with Yigal


  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $79 on, Tuesday, November 15th, 2022

Publication Contributing Sources